VOR: Vor Bio Inc. Future Price to Earnings

Vor Biopharma Inc. (VOR) efficiency relies on the flawless transport of biomaterials in nitrogen to preserve living cells. Simultaneously, the company is implementing robots for cell separation and AI systems for genome analysis. The development of blood cancer treatments makes the business significant, while the market fluctuations of the share price on GURU.Markets with a 0.00 indicator clearly demonstrate the company's current valuation.

Projected Price to Earnings Ratio: Vor Biopharma (VOR) for 07/04/2022 - 11/14/2026

Vor Bio Inc. (VOR) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price Vor Biopharma|VOR - Price Target Chart

- market capitalization information:

Market Value Vor Biopharma, Inc.|VOR - Total Company Value

- balance sheet equity data:

Net Assets per Single Share Vor Biopharma|VOR - Total Stockholders' Equity|Market Value to Book Value Ratio vorbio.com|VOR - Company Assets

- debt obligations and liquidity statistics:

- company profitability and valuation multiples indicators:

VOR - Final Profit|Projected Future Earnings Vor Biopharma Inc.|VOR - Price to Earnings Ratio|Forward P/E Multiple Vor Bio|VOR - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vor Biopharma, Inc.|VOR - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Vor Biopharma|VOR - Earnings per one share for the last 12 months|Quarterly EPS earnings growth vorbio.com|VOR - Earnings per share increase in current year|Earnings growth forecast for next year Vor Biopharma Inc.

- sales and revenue data:

VOR - Revenue and Sales Volume|Company Projected Revenue Vor Biopharma|VOR - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Vor Biopharma, Inc.

General company analysis:VOR Vor Biopharma

The forward P/E ratio assesses the current share price relative to expected earnings for the coming year. An increase in this ratio signals inflated market expectations, which elevates the risk of a correction following any negative data revision. By analyzing the NTM P/E of a company, an investor determines the extent to which an asset is overbought. For Vor Biopharma Inc. (VOR), this indicator is critical due to the toxicity risks associated with gene editing. Errors in clinical trials could nullify earnings forecasts, triggering a collapse in share prices.

Competitors of Vor Biopharma Inc. (VOR)